Publications

Search
Found 5 results
Filters: Author is Lexchin,J.  [Clear All Filters]
2002
Mintzes B, Barer ML, Kravitz RL, Kazanjian A, Bassett K, Lexchin J, et al. Influence of direct to consumer pharmaceutical advertising and patients' requests on prescribing decisions: two site cross sectional survey. BMJ (Clinical research ed.)BMJ. 2002;324(7332):278-279.
2003
Mintzes B, Barer ML, Kravitz RL, Bassett K, Lexchin J, Kazanjian A, et al. How does direct-to-consumer advertising (DTCA) affect prescribing? A survey in primary care environments with and without legal DTCA. CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienneCMAJ. 2003;169(5):405-412.
2005
Mintzes B, Barer ML, Lexchin J, Bassett KL. Introduction of direct-to-consumer advertising of prescription drugs in Canada: an opinion survey on regulatory policy. Research in social & administrative pharmacy : RSAPRes.Social Adm.Pharm.. 2005;1(2):310-330.
2011
Morgan SG, Grootendorst P, Lexchin J, Cunningham C, Greyson D. The cost of drug development: a systematic review. Health Policy. 2011;100(1):4-17.
2013
Mintzes B, Lexchin J, Sutherland J, Beaulieu M, Wilkes M, Durrieu G, et al. Pharmaceutical Sales Representatives and Patient Safety: A Comparative Prospective Study of Information Quality in Canada, France and the United States. Journal of General Internal Medicine. 2013.